Tom Moore

2.5k total citations · 1 hit paper
26 papers, 1.3k citations indexed

About

Tom Moore is a scholar working on Pulmonary and Respiratory Medicine, Immunology and Surgery. According to data from OpenAlex, Tom Moore has authored 26 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pulmonary and Respiratory Medicine, 8 papers in Immunology and 6 papers in Surgery. Recurrent topics in Tom Moore's work include Cardiovascular and Diving-Related Complications (6 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and CAR-T cell therapy research (5 papers). Tom Moore is often cited by papers focused on Cardiovascular and Diving-Related Complications (6 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and CAR-T cell therapy research (5 papers). Tom Moore collaborates with scholars based in United Kingdom, Switzerland and Germany. Tom Moore's co-authors include S. K. Hong, Sarah A. Hosgood, Yi‐Xin Lin, William Townsend, Randeep Sangha, Wolfram Klapper, Kaspar Rufibach, Rudolf Schlag, Michael Wenger and Stephen Opat and has published in prestigious journals such as New England Journal of Medicine, Blood and Scientific Reports.

In The Last Decade

Tom Moore

25 papers receiving 1.3k citations

Hit Papers

Obinutuzumab for the First-Line Treatment of Follicular L... 2017 2026 2020 2023 2017 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Obinutuzumab for the First-Line Treatment of Follicular Lymphoma
    2017 461 citations Robert Marcus, Andrew Davies et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tom Moore United Kingdom 16 470 399 301 251 243 26 1.3k
Kevin G. Moder United States 26 715 1.5× 243 0.6× 231 0.8× 101 0.4× 257 1.1× 64 2.5k
M Wolf Australia 18 524 1.1× 683 1.7× 91 0.3× 267 1.1× 205 0.8× 51 1.8k
Ana Ferrer Spain 21 609 1.3× 472 1.2× 106 0.4× 417 1.7× 200 0.8× 79 1.5k
Bruce F. Burns Canada 17 524 1.1× 350 0.9× 226 0.8× 150 0.6× 263 1.1× 53 1.1k
Roberto Gastaldi Italy 24 176 0.4× 144 0.4× 153 0.5× 173 0.7× 189 0.8× 73 1.7k
Michael Mian Italy 21 517 1.1× 353 0.9× 228 0.8× 260 1.0× 112 0.5× 82 1.1k
Guido Wilms Belgium 22 178 0.4× 258 0.6× 379 1.3× 288 1.1× 302 1.2× 76 1.5k
Laura Sainati Italy 26 168 0.4× 135 0.3× 144 0.5× 812 3.2× 293 1.2× 86 1.7k
Anne‐Sophie Michallet France 22 771 1.6× 362 0.9× 41 0.1× 728 2.9× 148 0.6× 93 1.5k
Hiroto Tsuboi Japan 23 148 0.3× 218 0.5× 484 1.6× 59 0.2× 110 0.5× 134 1.9k

Countries citing papers authored by Tom Moore

Since Specialization
Citations

This map shows the geographic impact of Tom Moore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tom Moore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tom Moore more than expected).

Fields of papers citing papers by Tom Moore

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tom Moore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tom Moore. The network helps show where Tom Moore may publish in the future.

Co-authorship network of co-authors of Tom Moore

This figure shows the co-authorship network connecting the top 25 collaborators of Tom Moore. A scholar is included among the top collaborators of Tom Moore based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tom Moore. Tom Moore is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hosgood, Sarah A., et al.. (2024). IL‐1 receptor antagonist anakinra downregulates inflammatory cytokines during renal normothermic machine perfusion: Preliminary results. Artificial Organs. 49(3). 451–459. 1 indexed citations
2.
Ferdinand, John R., Sarah A. Hosgood, Tom Moore, et al.. (2020). Cytokine absorption during human kidney perfusion reduces delayed graft function–associated inflammatory gene signature. American Journal of Transplantation. 21(6). 2188–2199. 50 indexed citations
3.
4.
5.
Bröske, Ann-Marie E, Ian James, Anton Belousov, et al.. (2019). CD20-TCB, a Novel T-Cell-Engaging Bispecific Antibody, Induces T-Cell-Mediated Killing in Relapsed or Refractory Non-Hodgkin Lymphoma: Biomarker Results From a Phase I Dose-Escalation Trial. Blood. 134(Supplement_1). 5319–5319. 5 indexed citations
6.
Hosgood, Sarah A., Tom Moore, Maria Qurashi, Tom Adams, & Michael L. Nicholson. (2018). Hydrogen Gas Does Not Ameliorate Renal Ischemia Reperfusion Injury in a Preclinical Model. Artificial Organs. 42(7). 723–727. 11 indexed citations
7.
Stilgenbauer, Stephan, Véronique Leblond, Robin Foà, et al.. (2018). Obinutuzumab plus bendamustine in previously untreated patients with CLL: a subgroup analysis of the GREEN study. Leukemia. 32(8). 1778–1786. 20 indexed citations
8.
Scott, Ian C., Jayesh B. Majithiya, Caroline Sandén, et al.. (2018). Interleukin-33 is activated by allergen- and necrosis-associated proteolytic activities to regulate its alarmin activity during epithelial damage. Scientific Reports. 8(1). 3363–3363. 84 indexed citations
9.
10.
Hosgood, Sarah A., et al.. (2017). Haemoadsorption reduces the inflammatory response and improves blood flow during ex vivo renal perfusion in an experimental model. Journal of Translational Medicine. 15(1). 216–216. 55 indexed citations
11.
Marcus, Robert, Andrew Davies, Kiyoshi Ando, et al.. (2017). Obinutuzumab for the First-Line Treatment of Follicular Lymphoma. New England Journal of Medicine. 377(14). 1331–1344. 461 indexed citations breakdown →
12.
Hosgood, Sarah A., Emily Thompson, Tom Moore, C. Wilson, & M L Nicholson. (2017). Normothermic machine perfusion for the assessment and transplantation of declined human kidneys from donation after circulatory death donors. British journal of surgery. 105(4). 388–394. 134 indexed citations
13.
Stilgenbauer, Stephan, Osman İlhan, Christoph Renner, et al.. (2015). Safety and Efficacy of Obinutuzumab Plus Bendamustine in Previously Untreated Patients with Chronic Lymphocytic Leukemia: Subgroup Analysis of the Green Study. Blood. 126(23). 493–493. 13 indexed citations
14.
Moore, Tom, et al.. (2000). Water Level Monitoring from Space. ESASP. 458. 105. 1 indexed citations
15.
Rotman, Harold H., et al.. (1983). Effects of low concentrations of chlorine on pulmonary function in humans. Journal of Applied Physiology. 54(4). 1120–1124. 31 indexed citations
16.
Moore, Tom. (1976). Urinary retention in women. BMJ. 2(6032). 421.3–421. 1 indexed citations
17.
Moore, Tom, et al.. (1975). Oxygen consumption and conservation during apnea in the anesthetized dog. Respiration Physiology. 24(3). 313–324.
18.
Lin, Yi‐Xin, et al.. (1974). Physiological and conventional breath-hold breaking points.. Journal of Applied Physiology. 37(3). 291–296. 116 indexed citations
19.
Moore, Tom, et al.. (1972). Effects of temperature, immersion, and ambient pressure on human apneic bradycardia.. Journal of Applied Physiology. 33(1). 36–41. 42 indexed citations
20.
Hong, S. K., et al.. (1970). Lung volumes and apneic bradycardia in divers. Journal of Applied Physiology. 29(2). 172–176. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kevin G. Moder Breakdown of academic impact, for papers by M Wolf Breakdown of academic impact, for papers by Ana Ferrer Breakdown of academic impact, for papers by Bruce F. Burns Breakdown of academic impact, for papers by Roberto Gastaldi Breakdown of academic impact, for papers by Michael Mian Breakdown of academic impact, for papers by Guido Wilms Breakdown of academic impact, for papers by Laura Sainati Breakdown of academic impact, for papers by Anne‐Sophie Michallet Breakdown of academic impact, for papers by Hiroto Tsuboi
Rankless by CCL
2026